These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12358005)

  • 21. Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses.
    Grause JF; Ueti MW; Nelson JT; Knowles DP; Kappmeyer LS; Bunn TO
    Vet J; 2013 Jun; 196(3):541-6. PubMed ID: 23199699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic and prophylactic efficacy of imidocarb dipropionate on experimental Babesia ovis infection of lambs.
    Sevinc F; Turgut K; Sevinc M; Ekici OD; Coskun A; Koc Y; Erol M; Ica A
    Vet Parasitol; 2007 Oct; 149(1-2):65-71. PubMed ID: 17709209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual effect of antibabesial drugs on the live redwater blood vaccines.
    Combrink MP; Troskie PC; De Waal DT
    Ann N Y Acad Sci; 2002 Oct; 969():169-73. PubMed ID: 12381585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.
    Kumar S; Gupta AK; Pal Y; Dwivedi SK
    J Vet Med Sci; 2003 Nov; 65(11):1171-7. PubMed ID: 14665744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate.
    Brandão LP; Hagiwara MK; Myiashiro SI
    Vet Parasitol; 2003 Jun; 114(4):253-65. PubMed ID: 12809752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parasitological and molecular diagnostic of a clinical Babesia caballi outbreak in Southern Romania.
    Ionita M; Nicorescu IM; Pfister K; Mitrea IL
    Parasitol Res; 2018 Jul; 117(7):2333-2339. PubMed ID: 29766270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residue depletion of imidocarb in Swine tissue.
    Wang Z; Li X; Su D; Li Y; Wu L; Wang Y; Wu W
    J Agric Food Chem; 2009 Mar; 57(6):2324-8. PubMed ID: 19243130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
    Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G
    Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depletion and bioavailability of imidocarb residues in sheep and goat tissues.
    Lai O; Belloli C; Crescenzo G; Carofiglio V; Ormas P; Marangi O; Cagnardi P
    Vet Hum Toxicol; 2002 Apr; 44(2):79-83. PubMed ID: 11931508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of imidocarb dipropionate prophylaxis on the infectivity and immunogenicity of a Babesia bovis vaccine in cattle.
    de Vos AJ; Dalgliesh RJ; McGregor W
    Aust Vet J; 1986 Jun; 63(6):174-8. PubMed ID: 3767795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor.
    Hines SA; Ramsay JD; Kappmeyer LS; Lau AO; Ojo KK; Van Voorhis WC; Knowles DP; Mealey RH
    Parasit Vectors; 2015 Jan; 8():33. PubMed ID: 25600252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of combination therapy with imidocarb dipropionate and toltrazuril to clear Hepatozoon canis infection in dogs.
    Pasa S; Voyvoda H; Karagenc T; Atasoy A; Gazyagci S
    Parasitol Res; 2011 Sep; 109(3):919-26. PubMed ID: 21472405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Babesiosis in a foal.
    Silvey RE
    Vet Rec; 1996 Oct; 139(17):428. PubMed ID: 9036621
    [No Abstract]   [Full Text] [Related]  

  • 34. Failure of imidocarb dipropionate to eliminate Hepatozoon canis in naturally infected dogs based on parasitological and molecular evaluation methods.
    Sasanelli M; Paradies P; Greco B; Eyal O; Zaza V; Baneth G
    Vet Parasitol; 2010 Aug; 171(3-4):194-9. PubMed ID: 20444549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration.
    Kaartinen L; Panu S; Pyörälä S
    Equine Vet J; 1997 Sep; 29(5):378-81. PubMed ID: 9306065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomal diamidine (imidocarb): preparation and animal studies.
    Timofeev BA; Bolotin IM; Stepanova LP; Bogdanov AA; Georgiu K; Malyshev SN; Petrovsky VV; Klibanov AL; Torchilin VP
    J Microencapsul; 1994; 11(6):627-32. PubMed ID: 7884627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, toxicity and metabolism of imidocarb dipropionate in the treatment of Babesia ovis infection in sheep.
    McHardy N; Woollon RM; Clampitt RB; James JA; Crawley RJ
    Res Vet Sci; 1986 Jul; 41(1):14-20. PubMed ID: 3764099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic activity of imidocarb against experimental infection with Babesia canis.
    Vercammen F; De Deken R; Maes L
    Vet Parasitol; 1996 Jun; 63(3-4):195-8. PubMed ID: 8966987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equine piroplasmosis (Babesia equi): therapeutic trials of imidocarb dihydrochloride in horses and donkeys.
    Frerichs WM; Allen PC; Holbrook AA
    Vet Rec; 1973 Jul; 93(3):73-5. PubMed ID: 4748680
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dimidin and imidocarb in piroplasmosis].
    Rakhimov TKh; Shmunk EK; Tursunov MT; Tashtemirov N; Gafurov A
    Veterinariia; 1977 Oct; (10):75-7. PubMed ID: 919321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.